Related Party Transactions (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 23, 2026 |
Mar. 26, 2026 |
May 08, 2023 |
Aug. 29, 2022 |
Aug. 29, 2022 |
Jul. 26, 2022 |
Oct. 13, 2021 |
Sep. 10, 2020 |
Jan. 31, 2021 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Aug. 31, 2025 |
|
| Related Party Transaction [Line Items] | ||||||||||||||||
| Fair value of marketable securities | $ 1,090,000 | $ 1,090,000 | $ 2,694,000 | |||||||||||||
| Unrealized gain loss on investments | (13,702,000) | (17,172,000) | ||||||||||||||
| Number of shares issued | 703,000 | |||||||||||||||
| Interest expense | 89,000 | $ 123,000 | $ 128,000 | $ 156,000 | ||||||||||||
| Securities Purchase Agreement [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Simple interest rate | 3.00% | |||||||||||||||
| Converted outstanding price | $ 0.45 | $ 0.74 | ||||||||||||||
| Purchase of warrant | 16,554,055 | |||||||||||||||
| Exercise price | $ 0.93 | |||||||||||||||
| Allocated description | The Company allocated the $2,450,000 proceeds between the convertible note and warrant based on their relative fair values. The warrant valuation was determined using a Black-Scholes option-pricing model. Significant valuation inputs included the Company’s common stock price of $0.91 per share, exercise price of $0.93 per share, expected term of 5.0 years, risk-free rate of 4.0%, selected volatility of 85.0%, expected dividend rate of 0.0%, and 16,554,055 warrants outstanding. Based on these inputs, the calculated warrant value was $0.63 per warrant, resulting in an indicated fair value of $10,368,000. The fair value of the convertible note was determined using valuation techniques that considered the contractual note terms, conversion feature, most favored nation provision, Company-specific credit risk, market interest rates, expected volatility, and probability-weighted conversion scenarios. The valuation considered two scenarios: a no subsequent convertible instrument issuance before expiration scenario, with an indicated value of $3,418,000. For purposes of allocating the $2,450,000 proceeds at issuance, the Company used the relative fair values of the warrant and convertible note. Accordingly, $1,843,000 was allocated to the warrant and recorded in additional paid-in capital, and $607,000 was allocated to the note. The allocation resulted in a debt discount of $1,843,000, which will be amortized to interest expense over the five-year term of the note using the effective interest method. As of June 30, 2026, the note had a principal amount of $2,450,000, unamortized debt discount of approximately $1,792,000 and a net carrying amount of approximately $658,000. The debt discount is being amortized to interest expense over the five-year contractual term of the note using the effective interest method. | |||||||||||||||
| Convertible Promissory Note [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Simple interest rate | 3.00% | |||||||||||||||
| Purchase of warrant | 17,777,776 | |||||||||||||||
| Exercise price | $ 0.50 | |||||||||||||||
| Securities Purchase Agreement Convertible Promissory Note [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Allocated description | The Company allocated the $1,000,000 of proceeds between the convertible note and warrants based on their relative fair values in accordance with ASC 470-20-30-1 and ASC 470-20-30-2. The warrant valuation was determined using a Black-Scholes option-pricing model. Significant valuation inputs included the Company’s common stock price of $0.61 per share, exercise price of $0.50 per share, expected term of 3.0 years, risk-free interest rate of 4.2%, selected volatility of 85.0%, expected dividend rate of 0.0%, and 17,777,776 warrants outstanding. Based on these inputs, the calculated warrant value was $0.37 per warrant, resulting in an indicated fair value of $6,651,000. The fair value of the convertible note at issuance was determined using a binomial lattice model that considered the contractual note terms, conversion feature, Company-specific credit risk, market interest rates, expected volatility, and the Company’s redemption right. Significant valuation inputs included the Company’s common stock price of $0.61 per share, conversion price of $0.45 per share, contractual term of 5.0 years, risk-free interest rate of 4.2%, selected volatility of 85.0%, and discount rate of 13.25%. Based on these inputs, the indicated fair value of the convertible note at issuance was $1,531,000. For purposes of allocating the $1,000,000 of proceeds at issuance, the Company used the relative fair values of the warrants and convertible note. Accordingly, $813,000 was allocated to the warrants and recorded in additional paid-in capital, and $187,000 was allocated to the note. The allocation resulted in an initial debt discount of $813,000, which is being amortized to interest expense over the five-year contractual term of the note using the effective interest method. As of June 30, 2026, the note had a principal amount of $1,000,000, an unamortized debt discount of approximately $812,000, and a net carrying amount of approximately $188,000. | |||||||||||||||
| Fair value of note | 1,495,000 | $ 1,495,000 | ||||||||||||||
| BMIC Loan [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Face amount | $ 3,000,000 | 33,000 | 33,000 | 33,000 | ||||||||||||
| Maturity date | July 2026 | July 2026 | ||||||||||||||
| Wilson Loan [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Face amount | $ 3,000,000 | 145,000 | 145,000 | 145,000 | ||||||||||||
| Maturity date | July 2026 | July 2026 | ||||||||||||||
| Alset Note [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Face amount | 529,000 | 529,000 | 512,000 | |||||||||||||
| Interest expense | 17,000 | 0 | ||||||||||||||
| Convertible Bond Investment [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Convertible bond investment fair value | $ 2,450,000 | |||||||||||||||
| Convertible Promissory Note [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Maturity date | June 23, 2031 | |||||||||||||||
| Convertible bond investment fair value | $ 1,000,000 | |||||||||||||||
| Proceeds from issuance of convertible promissory note | $ 1,000,000 | |||||||||||||||
| Note 4 [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Face amount | $ 100,000 | $ 100,000 | ||||||||||||||
| Simple interest rate | 8.00% | 8.00% | ||||||||||||||
| Debt instrument maturity date | Aug. 29, 2025 | Aug. 29, 2025 | ||||||||||||||
| Notes and loans receivable gross current | 86,000 | 86,000 | 86,000 | |||||||||||||
| Note 5 [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Face amount | $ 102,000 | |||||||||||||||
| Simple interest rate | 2.00% | |||||||||||||||
| Debt instrument maturity date | May 07, 2026 | |||||||||||||||
| Notes and loans receivable gross current | 110,000 | 110,000 | 110,000 | |||||||||||||
| Note 6 [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Face amount | $ 1,000,000 | |||||||||||||||
| Simple interest rate | 8.00% | |||||||||||||||
| Debt instrument maturity date | Jul. 26, 2024 | |||||||||||||||
| Notes and loans receivable gross current | $ 917,000 | 917,000 | 917,000 | |||||||||||||
| BMI Capital International LLC [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Number of shares issued | $ 100,000 | |||||||||||||||
| Equity method investment | $ 13,000 | 5,000 | ||||||||||||||
| DSS Securities, Inc. [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Equity method investment ownership percentage | 14.90% | |||||||||||||||
| BMI Capital International LLC [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Equity method investment ownership percentage | 24.90% | 24.90% | 24.90% | |||||||||||||
| BMI Capital Inc [Member] | Note 4 [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Equity method investment ownership percentage | 24.90% | 24.90% | ||||||||||||||
| BMI Capital Inc [Member] | Note 5 [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Equity method investment ownership percentage | 24.90% | |||||||||||||||
| Alset International Limited [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Investment owned | 127,179,291 | 127,179,291 | ||||||||||||||
| Percentage of outstanding shares | 4.00% | |||||||||||||||
| Fair value of marketable securities | $ 1,666,000 | $ 1,666,000 | 2,277,000 | |||||||||||||
| Unrealized gain loss on investments | 610,000 | 420,000 | ||||||||||||||
| DSS Securities, Inc. [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Number of shares issued | $ 100,000 | |||||||||||||||
| Outstanding membership interest | 10.00% | |||||||||||||||
| Alset, Inc. [Member] | ||||||||||||||||
| Related Party Transaction [Line Items] | ||||||||||||||||
| Face amount | $ 529,000 | $ 529,000 | $ 512,000 | |||||||||||||
| Simple interest rate | 6.75% | 7.25% | 6.75% | |||||||||||||
| Convertible promissory note | $ 500,000 | |||||||||||||||
| Price per share | $ 0.86 | |||||||||||||||
| Interest expense | $ 17,000 | $ 0 | ||||||||||||||